CYTOO

CYTOO is a preclinical and clinical-stage drug discovery biotech company focusing on disorders affecting muscle health. CYTOO has pioneered the ability to control cells microenvironment and has developed a platform of micropattern technologies to enable significantly greater physiologically relevant cellular models in comparison to standard techniques used by most labs and... CYTOO's solutions can transform conventional cellular models grown as heterogeneous monolayers into a more in-vivo like phenotype and morphology through cell micropatterning (shown to modulate genomic transcription after restituting physical cues). The unique approach can then enable simple conversion of poorly predictable and robust, and low throughput assays, into highly reliable and data rich high content screening efforts... The information collected through this form is recorded and transmitted to the relevant departments of CYTOO, and allows us to send you our newsletter concerning the services we offer...

Also known as: CYTOO Inc., CYTOO SA

Primary location: Cambridge United States